Cargando…
The P2X7 Receptor as a Mechanistic Biomarker for Epilepsy
Epilepsy, characterized by recurrent spontaneous seizures, is a heterogeneous group of brain diseases affecting over 70 million people worldwide. Major challenges in the management of epilepsy include its diagnosis and treatment. To date, video electroencephalogram (EEG) monitoring is the gold-stand...
Autor principal: | Engel, Tobias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049244/ https://www.ncbi.nlm.nih.gov/pubmed/36982485 http://dx.doi.org/10.3390/ijms24065410 |
Ejemplares similares
-
Beyond Seizure Control: Treating Comorbidities in Epilepsy via Targeting of the P2X7 Receptor
por: Gil, Beatriz, et al.
Publicado: (2022) -
Circulating P2X7 Receptor Signaling Components as Diagnostic Biomarkers for Temporal Lobe Epilepsy
por: Conte, Giorgia, et al.
Publicado: (2021) -
The ATP-Gated P2X7 Receptor As a Target for the Treatment of Drug-Resistant Epilepsy
por: Beamer, Edward, et al.
Publicado: (2017) -
Inherent P2X7 Receptors Regulate Macrophage Functions during Inflammatory Diseases
por: Ren, Wenjing, et al.
Publicado: (2021) -
Targeting Neuroinflammation via Purinergic P2 Receptors for Disease Modification in Drug-Refractory Epilepsy
por: Engel, Tobias, et al.
Publicado: (2021)